标签：#longevity

The lab will beam back data to train AI models to predict how proteins behind age-related diseases like Alzheimer’s and certain cancers behave.

The FDA recently approved the cellular rejuvenation therapy ER-100 for human clinical trials. While vision is the first target, it could have applications for a variety of age-related disease.